SANUWAVE Health, Inc.
NASDAQ:SNWVMedical - Devices
+$0.18 today
- Market cap
- $51.01M
- Beta
- 1.35
- P/E (TTM)
- 5.0
- EPS (TTM)
- $1.87
Volume 0.04M
Average 0.11M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
SANUWAVE Health, Inc.
NASDAQ:SNWV
Intrinsic Alpha fair value
Locked
Current Price
$5.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +38.1% | -7.7% (6yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at +38.1% over three years. Forward estimates point to Revenue at -7.7% (6yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Sight Sciences, Inc. NASDAQ:SGHT | $406.44M | $7.47 | Not rated | -7.5 | +59.94% |
908 Devices Inc. NASDAQ:MASS | $364.32M | $8.88 | Not rated | -9.0 | +64.39% |
Foghorn Therapeutics Inc. NASDAQ:FHTX | $356.39M | $6.07 | Not rated | -3.8 | -61.22% |
Senseonics Holdings, Inc. NASDAQ:SENS | $293.39M | $7.02 | Not rated | -3.5 | +68.98% |
Quanterix Corporation NASDAQ:QTRX | $189.84M | $4.03 | Not rated | -1.5 | -65.65% |
Inogen, Inc. NASDAQ:INGN | $163.80M | $6.05 | Not rated | -7.0 | -17.75% |
Immuneering Corporation NASDAQ:IMRX | $163.72M | $4.51 | Not rated | -3.6 | -50.64% |
Solana Company NASDAQ:HSDT | $98.67M | $1.69 | Not rated | -0.9 | -48.92% |
Outset Medical, Inc. NASDAQ:OM | $90.83M | $4.90 | Not rated | -1.2 | -34.46% |
Nano-X Imaging Ltd. NASDAQ:NNOX | $73.78M | $1.06 | Not rated | -1.5 | -78.79% |
Continue the stock analysis
Jump to another research area for this company.